Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease

Gut

Volumn 61, Issue 1, 2012, Pages 78-85

  Peyrin Biroulet, Laurent ^a,b,c   Gonzalez, Florent ^a,b,c   Dubuquoy, Laurent ^a,b,c   Rousseaux, Christel ^a,b,c   Dubuquoy, Caroline ^a,b,c   Decourcelle, Cécilia ^a,b,c   Saudemont, Alain ^c   Tachon, Mickael ^a,b,c   Béclin, Elodie ^a,b,c   Odou, Marie Françoise ^a,b,c   Neut, Christel ^a,b,c   Colombel, Jean Frédéric ^a,b,c   Desreumaux, Pierre ^a,b,c  

^a UNIV LILLE   (France)

^b UNIVERSITÉ DE LILLE   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; CELL LINE; CELL STRAIN 3T3; CLINICAL ARTICLE; COLITIS; CONTROLLED STUDY; CROHN DISEASE; ESCHERICHIA COLI; EXPERIMENTAL MODEL; FEMALE; HUMAN; HUMAN TISSUE; HYPERPLASIA; ILEITIS; INFLAMMATION; MALE; MESENTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; SUBCUTANEOUS FAT;

ABDOMINAL FAT; ADULT; ANIMALS; BACTERIAL TRANSLOCATION; C-REACTIVE PROTEIN; CELL LINE; COLITIS, ULCERATIVE; CROHN DISEASE; ESCHERICHIA COLI; FEMALE; HUMANS; ILEITIS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LYMPH NODES; MALE; MESENTERY; MICE; PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 83555177321     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-300370     Document Type: Article

References (37)

1. Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem 2004;279:48487-90. (Pubitemid 39625721)
2. Bottazzi B, Doni A, Garlanda C, et al. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol 2010;28:157-83.
3. Henriksen M, Jahnsen J, Lygren I, et al. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Gut 2008;57:1518-23.
4. Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010;362:1383-95.
5. Treton X, Bouhnik Y, Mary JY, et al. Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse. Clin Gastroenterol Hepatol 2009;7:80-5.
6. Peyrin-Biroulet L, Chamaillard M, Gonzalez F, et al. Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander? Gut 2007;56:577-83. (Pubitemid 46580516)
7. Anty R, Bekri S, Luciani N, et al. The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH. Am J Gastroenterol 2006;101:1824-33.
8. Greenfield JR, Samaras K, Jenkins AB, et al. Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences. Circulation 2004;109:3022-8. (Pubitemid 38808325)
9. Colombel JF, Solem CA, Sandborn WJ, et al. Quantitative measurement and visual assessment of ileal Crohn's disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein. Gut 2006; 55:1561-7. (Pubitemid 44629202)
10. Bataille R, Klein B. C-reactive protein levels as a direct indicator of interleukin-6 levels in humans in vivo. Arthritis Rheum 1992;35:982-4.
11. Desreumaux P, Ernst O, Geboes K, et al. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology 1999;117:73-81. (Pubitemid 29297622)
12. Sedman PC, Macfie J, Sagar P, et al. The prevalence of gut translocation in humans. Gastroenterology 1994;107:643-9. (Pubitemid 24265509)
13. Batra A, Zeitz M, Siegmund B. Adipokine signaling in inflammatory bowel disease. Inflamm Bowel Dis 2009;15:1897-905.
14. Batra A, Pietsch J, Fedke I, et al. Leptin-dependent toll-like receptor expression and responsiveness in preadipocytes and adipocytes. Am J Pathol 2007;170:1931-41. (Pubitemid 47339267)
15. Vitseva OI, Tanriverdi K, Tchkonia TT, et al. Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue. Obesity (Silver Spring) 2008;16:932-7. (Pubitemid 351620468)
16. Stroh T, Batra A, Glauben R, et al. Nucleotide oligomerization domains 1 and 2: regulation of expression and function in preadipocytes. J Immunol 2008;181:3620-7.
17. Declercq C, Gower-Rousseau C, Vernier-Massouille G, et al. Mapping of inflammatory bowel disease in northern France: spatial variations and relation to affluence. Inflamm Bowel Dis 2010;16:807-12.
18. Franchimont D, Roland S, Gustot T, et al. Impact of infliximab on serum leptin levels in patients with Crohn's disease. J Clin Endocrinol Metab 2005;90:3510-16. (Pubitemid 41014321)
19. Lin Y, Lee H, Berg AH, et al. The lipopolysaccharide-activated toll-like receptor (TLR)- 4 induces synthesis of the closely related receptor TLR-2 in adipocytes. J Biol Chem 2000;275:24255-63. (Pubitemid 30626513)
20. Hoch M, Eberle AN, Peterli R, et al. LPS induces interleukin-6 and interleukin-8 but not tumor necrosis factor-alpha in human adipocytes. Cytokine 2008;41:29-37. (Pubitemid 350309715)
21. Netea MG, Ferwerda G, de Jong DJ, et al. Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. J Immunol 2005;174:6518-23. (Pubitemid 40663847)
22. Yamamoto K, Kiyohara T, Murayama Y, et al. Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn's disease. Gut 2005;54:789-96. (Pubitemid 40732095)
23. Neut C, Bulois P, Desreumaux P, et al. Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease. Am J Gastroenterol 2002;97:939-46. (Pubitemid 34408252)
24. Berg RD, Garlington AW. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun 1979;23:403-11. (Pubitemid 9119845)
25. Desreumaux P, Dubuquoy L, Nutten S, et al. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies. J Exp Med 2001;193:827-38. (Pubitemid 32524532)
26. Gatt M, Reddy BS, MacFie J. Review article: bacterial translocation in the critically ill-evidence and methods of prevention. Aliment Pharmacol Ther 2007;25:741-57. (Pubitemid 46437210)
27. Piepoli AL, De Salvatore G, De Salvia MA, et al. Indomethacin-induced ileitis is associated with tensiometric, vascular and oxidative changes in the experimental rat model. Eur J Clin Invest 2005;35:271-8. (Pubitemid 40546926)
28. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006;55:749-53. (Pubitemid 43764536)
29. Khazen W, M'Bika JP, Collinet M, et al. Differentiation-dependent expression of interferon gamma and toll-like receptor 9 in 3T3-F442A adipocytes. Biochimie 2007;89:669-75. (Pubitemid 46669779)
30. Memoli B, Procino A, Calabro P, et al. Inflammation may modulate IL-6 and C-reactive protein gene expression in the adipose tissue: the role of IL-6 cell membrane receptor. Am J Physiol Endocrinol Metab 2007;293:E1030-5.
31. Ouchi N, Kihara S, Funahashi T, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003;107:671-4. (Pubitemid 36222590)
32. Cellier C, Sahmoud T, Froguel E, et al. Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Gut 1994;35:231-5. (Pubitemid 24092870)
33. Calabro P, Chang DW, Willerson JT, et al. Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. J Am Coll Cardiol 2005;46:1112-13. (Pubitemid 41316523)
34. Weinhold B, Bader A, Poli V, et al. Interleukin-6 is necessary, but not sufficient, for induction of the human C-reactive protein gene in vivo. Biochem J 1997;325:617-21. (Pubitemid 27367749)
35. Pietsch J, Batra A, Stroh T, et al. Toll-like receptor expression and response to specific stimulation in adipocytes and preadipocytes: on the role of fat in inflammation. Ann N Y Acad Sci 2006;1072:407-9. (Pubitemid 44448475)
36. Dhurandhar NV, Israel BA, Kolesar JM, et al. Increased adiposity in animals due to a human virus. Int J Obes Relat Metab Disord 2000;24:989-96. (Pubitemid 30618118)
37. Schaffler A, Scholmerich J. Innate immunity and adipose tissue biology. Trends Immunol 2010;31:228-35.